310 related articles for article (PubMed ID: 14684628)
1. PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation.
Meissner M; Stein M; Urbich C; Reisinger K; Suske G; Staels B; Kaufmann R; Gille J
Circ Res; 2004 Feb; 94(3):324-32. PubMed ID: 14684628
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Rac1 GTPase downregulates vascular endothelial growth factor receptor-2 expression by suppressing Sp1-dependent DNA binding in human endothelial cells.
Meissner M; Michailidou D; Stein M; Hrgovic I; Kaufmann R; Gille J
Exp Dermatol; 2009 Oct; 18(10):863-9. PubMed ID: 19469899
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells.
Meissner M; Reichenbach G; Stein M; Hrgovic I; Kaufmann R; Gille J
Cancer Res; 2009 Mar; 69(5):1976-84. PubMed ID: 19223539
[TBL] [Abstract][Full Text] [Related]
5. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
[TBL] [Abstract][Full Text] [Related]
6. PPARδ agonists suppress angiogenesis in a VEGFR2-dependent manner.
Meissner M; Hrgovic I; Doll M; Kaufmann R
Arch Dermatol Res; 2011 Jan; 303(1):41-7. PubMed ID: 21046127
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway.
Delerive P; Martin-Nizard F; Chinetti G; Trottein F; Fruchart JC; Najib J; Duriez P; Staels B
Circ Res; 1999 Sep; 85(5):394-402. PubMed ID: 10473669
[TBL] [Abstract][Full Text] [Related]
8. Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element.
Gervois P; Chopin-Delannoy S; Fadel A; Dubois G; Kosykh V; Fruchart JC; Najïb J; Laudet V; Staels B
Mol Endocrinol; 1999 Mar; 13(3):400-9. PubMed ID: 10076997
[TBL] [Abstract][Full Text] [Related]
9. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.
Schoonjans K; Peinado-Onsurbe J; Lefebvre AM; Heyman RA; Briggs M; Deeb S; Staels B; Auwerx J
EMBO J; 1996 Oct; 15(19):5336-48. PubMed ID: 8895578
[TBL] [Abstract][Full Text] [Related]
10. PPARalpha activation by Wy 14643 induces transactivation of the rat UCP-1 promoter without increasing UCP-1 mRNA levels and attenuates PPARgamma-mediated increases in UCP-1 mRNA levels induced by rosiglitazone in fetal rat brown adipocytes.
Teruel T; Clapham JC; Smith SA
Biochem Biophys Res Commun; 1999 Oct; 264(2):311-5. PubMed ID: 10529360
[TBL] [Abstract][Full Text] [Related]
11. PPAR activators inhibit endothelial cell migration by targeting Akt.
Goetze S; Eilers F; Bungenstock A; Kintscher U; Stawowy P; Blaschke F; Graf K; Law RE; Fleck E; Gräfe M
Biochem Biophys Res Commun; 2002 May; 293(5):1431-7. PubMed ID: 12054675
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells.
Goya K; Sumitani S; Xu X; Kitamura T; Yamamoto H; Kurebayashi S; Saito H; Kouhara H; Kasayama S; Kawase I
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):658-63. PubMed ID: 14751809
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cytokine-induced matrix metalloproteinase 9 expression by peroxisome proliferator-activated receptor alpha agonists is indirect and due to a NO-mediated reduction of mRNA stability.
Eberhardt W; Akool el-S; Rebhan J; Frank S; Beck KF; Franzen R; Hamada FM; Pfeilschifter J
J Biol Chem; 2002 Sep; 277(36):33518-28. PubMed ID: 12093797
[TBL] [Abstract][Full Text] [Related]
14. DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha.
Delerive P; De Bosscher K; Vanden Berghe W; Fruchart JC; Haegeman G; Staels B
Mol Endocrinol; 2002 May; 16(5):1029-39. PubMed ID: 11981037
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.
Takano H; Nagai T; Asakawa M; Toyozaki T; Oka T; Komuro I; Saito T; Masuda Y
Circ Res; 2000 Sep; 87(7):596-602. PubMed ID: 11009565
[TBL] [Abstract][Full Text] [Related]
16. Suppression of VEGFR2 expression in human endothelial cells by dimethylfumarate treatment: evidence for anti-angiogenic action.
Meissner M; Doll M; Hrgovic I; Reichenbach G; König V; Hailemariam-Jahn T; Gille J; Kaufmann R
J Invest Dermatol; 2011 Jun; 131(6):1356-64. PubMed ID: 21430706
[TBL] [Abstract][Full Text] [Related]
17. PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.
Marx N; Kehrle B; Kohlhammer K; Grüb M; Koenig W; Hombach V; Libby P; Plutzky J
Circ Res; 2002 Apr; 90(6):703-10. PubMed ID: 11934839
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine.
Koyama S; Takagi H; Otani A; Oh H; Nishimura K; Honda Y
Br J Pharmacol; 2002 Nov; 137(6):901-9. PubMed ID: 12411422
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.
Grau R; Punzón C; Fresno M; Iñiguez MA
Biochem J; 2006 Apr; 395(1):81-8. PubMed ID: 16343055
[TBL] [Abstract][Full Text] [Related]
20. Nuclear receptors modulate the interaction of Sp1 and GC-rich DNA via ternary complex formation.
Husmann M; Dragneva Y; Romahn E; Jehnichen P
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):763-72. PubMed ID: 11104684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
